跳至主要内容
临床试验/ISRCTN10514229
ISRCTN10514229已完成未知

Imaging NeuroVascular, Endothelial and STructural Integrity in prepAration to TrEat Small Vessel Diseases

Academic and Clinical Central Office for Research and Development (ACCORD)0 个研究点目标入组 78 人开始时间: 2016年5月23日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
78

研究概览

简要总结

2021 Protocol article in https://doi.org/10.1016/j.cccb.2021.100020 (added 16/08/2022) 2021 Abstract results in https://doi.org/10.1177/23969873211034932 (added 05/06/2024)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Age 18 years or older
  • 2. Able to undergo MRI
  • 3. Capacity to give written informed consent
  • 4. Symptomatic SVD defined as:
  • 4.1. A history of clinical lacunar stroke syndrome in the last 5 years with a recent small subcortical infarct visible on MRI scan or CT scan* compatible with the clinical syndrome.
  • 4.2. A diagnosis of CADASIL established by molecular genetic testing of the NOTCH3 gene (presence of an archetypical, cysteine-affecting mutation) or the presence of granular osmiophilic material (GOM) in ultrastructural, electron microscopy analysis of skin biopsy
  • *On MRI, a recent infarct is defined as a DWI lesion on the acute MRI scan. On CT, recent infarct is defined as a novel lacune on CT within 3 weeks after the event that was not visible on the admission CT.
  • or cognitive impairment defined as visiting a memory clinic and a clinical dementia rating [CDR] score of = 0.5, and capacity to consent with confluent deep white matter hyperintensities (WMH) on MRI (defined on the Fazekas scale as deep WMH score = 2)

排除标准

  • 1. Inclusion criteria are not met
  • 2. Unwillingness or inability to give written consent
  • 3. Pregnant or breastfeeding women, women of childbearing age not taking contraception.
  • 4. Acceptable contraception in women of childbearing age is a highly effective” contraceptive measure as defined by the Clinical Trials Facilitation Group (http://www.hma.eu/fileadmin/dateien/Human_Medicines/01-About_HMA/Working_Groups/CTFG/2014_09_HMA_CTFG_Contraception.pdf) and includes combined (oestrogen and progesterone containing) or progesterone-only contraception associated with inhibition of ovulation, or intrauterine device or bilateral tubal occlusion
  • 5. Contraindications to MRI (pacemaker, aneurysm clip, cochlear implant etc.)
  • 6. Contraindications to gadolinium contrast agent used for MRI
  • 7. Other major neurological or psychiatric conditions affecting the brain and interfering with the study design (e.g. multiple sclerosis)
  • 8. In case of clinical lacunar stroke syndrome other causes of stroke such as:
  • 8.1. =50% luminal stenosis (NASCET) in large arteries supplying the area of ischaemia
  • 8.2. Major-risk cardioembolic source of embolism (permanent or paroxysmal atrial fibrillation, sustained atrial flutter, intracardiac thrombus, prosthetic cardiac valve, atrial myxoma or other cardiac tumours, mitral stenosis, recent (<4 weeks) myocardial infarction, left ventricular ejection fraction less than 30%, valvular vegetations, or infective endocarditis)
  • 8.3. Other specific causes of stroke identified (e.g. arteritis, dissection, migraine/vasospasm, drug misuse)
  • 9. Other stroke risk factor requiring immediate intervention that would preclude involvement in the study
  • 10. Renal impairment (eGFR <30 ml/min)

研究者

发起方
Academic and Clinical Central Office for Research and Development (ACCORD)

相似试验